An endometrial thickness of 4 mm is considered normal in several common situations: after menopause without hormone therapy, during or just after menstruation in reproductive-age women, and while taking combined oral contraceptives. Whether that number is reassuring or concerning depends almost entirely on context, specifically your age, menstrual status, symptoms, and what medications you take. The lining of the uterus is not a fixed structure; it changes constantly in response to hormones, and the same measurement can mean very different things in a 30-year-old trying to conceive versus a 65-year-old with unexpected bleeding.
After Menopause, 4 mm Is Typically the Dividing Line
The most widely used clinical guideline for postmenopausal women experiencing vaginal bleeding sets 4 mm as the cutoff: at or below that thickness, the risk of endometrial cancer is low enough that many clinicians consider the measurement reassuring. This threshold has been standard practice for decades and is the reason a 4 mm reading shows up so frequently on ultrasound reports. The idea is straightforward. After menopause, estrogen levels drop, and the uterine lining thins out. A lining that stays thin is behaving as expected.
For postmenopausal women who have no bleeding at all, the picture gets murkier. Incidental findings of endometrial thickness above 4 mm on ultrasound are common, and they generate a lot of referrals and anxiety. A 2024 systematic review pooling data from over 4,000 asymptomatic postmenopausal women found no clear statistical relationship between any specific thickness cutoff and the likelihood of endometrial cancer or precancerous changes.1ScienceDirect. The optimal endometrial thickness threshold for prediction of endometrial cancer in postmenopausal women without bleeding remains uncertain In other words, the well-known 4 mm rule that works reasonably well for women with bleeding has not been validated as a reliable screening tool for women without symptoms. A Canadian guideline published the same year specifically recommended against routine investigation of thickened endometrium found incidentally in asymptomatic postmenopausal women, arguing that the resulting biopsies cause unnecessary pain, anxiety, and procedural risk without meaningfully improving cancer detection.2PubMed. Guideline No. 451: Asymptomatic Endometrial Thickening in Postmenopausal Women
One study of 154 asymptomatic postmenopausal women with incidentally discovered thick linings (ranging from about 4 mm to 28 mm) found that only one woman had cancer, and her measurement was 24 mm. None of the women with measurements in the lower range had cancer or atypical cells on biopsy.3PubMed. Asymptomatic thickened endometrium in postmenopausal women: malignancy risk The most common finding by far was benign polyps. So if you are postmenopausal, have no bleeding, and an ultrasound incidentally shows a lining of 4 mm, that is about as unremarkable as it gets.
During the Menstrual Cycle, 4 mm Is an Early-Phase Measurement
In women of reproductive age, endometrial thickness follows a predictable monthly rhythm driven by estrogen and progesterone. Right after menstruation, the lining is at its thinnest, often around 2 to 4 mm. As estrogen rises during the first half of the cycle, the lining builds up progressively. By the time of ovulation, it commonly reaches 8 to 12 mm or more. After ovulation, progesterone transforms the tissue further, and the lining stabilizes or thickens slightly before being shed again if pregnancy does not occur.4PubMed Central. Thickened Endometrium: When to Intervene? A Clinical Conundrum
A measurement of 4 mm in a reproductive-age woman is therefore perfectly normal during or immediately after a period. It would raise questions if it appeared at mid-cycle or in the second half of the cycle, because that would suggest the lining is not responding to estrogen the way it should. Conditions that suppress estrogen, like very low body weight, extreme exercise, or certain pituitary disorders, can keep the lining persistently thin even when it should be thickening. The timing of the measurement matters enormously, and an ultrasound report that does not note where you are in your cycle is missing the single most important piece of context.
Why Oral Contraceptives Keep the Lining at Around 4 mm
If you take combined oral contraceptives, a thin lining is not just normal but expected. The synthetic hormones in the pill suppress the natural cycle of endometrial growth and breakdown. One study found that women on combination pills maintained an average endometrial thickness of about 4 mm, comparable to what you would see during menstruation. That is dramatically thinner than the 11 to 12 mm typical of the late follicular or luteal phase in women who are not on hormonal birth control.5PubMed. Oral contraceptives maintain a very thin endometrium before operative hysteroscopy
This thinning effect is actually useful in clinical practice. Surgeons sometimes prescribe a short course of oral contraceptives before procedures like hysteroscopy specifically to produce a thin, uniform lining that is easier to evaluate. So if you are on the pill and an ultrasound shows 4 mm, there is nothing to investigate. The medication is doing what it is designed to do.
Hormone Replacement Therapy Changes the Baseline
For postmenopausal women on hormone replacement therapy, the expected thickness shifts depending on the type of regimen. Sequential HRT, which mimics the natural cycle by alternating estrogen and progesterone, tends to thicken the lining significantly. One study found a mean thickness of about 8 mm in women on sequential hormones, compared with 5 mm in untreated controls, with the thickest measurements appearing in the middle of the progestogen phase.6PubMed. Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy
Continuous combined HRT, which delivers both hormones every day without cycling, has a very different effect. A study comparing the two approaches found that after six months, women on sequential HRT had a mean endometrial thickness of about 8.5 mm, while those on continuous combined therapy averaged just 3.6 mm, with over 90% of that group measuring at or below 4 mm.7PubMed. Ultrasonographic measurement of endometrial thickness during hormonal replacement therapy in postmenopausal women So a reading of 4 mm in a woman on continuous combined HRT is right in line with expectations. The same reading in a woman on sequential HRT would be on the lower end but still within normal range, especially if the scan happened early in her hormone cycle.
When 4 mm Is Too Thin for Fertility
The context where 4 mm becomes genuinely concerning is when you are trying to get pregnant. A thicker endometrial lining gives an embryo a better surface for implantation, and most fertility specialists consider anything below about 7 or 8 mm on the day of embryo transfer or ovulation to be suboptimal. At 4 mm, the odds of successful implantation drop considerably.
A review of the evidence on thin endometrium and assisted reproduction found that while pregnancies have been reported at 4 and 5 mm, thickness below 6 mm is associated with a clear trend toward lower pregnancy rates.8PubMed Central. The endometrium in assisted reproductive technology: How thin is thin? A larger study looking at outcomes across different thickness ranges reported that clinical pregnancy rates were about 50% in women with a lining of 6 mm or less, compared with over 80% in those whose lining exceeded 16 mm. Live birth rates showed a similar gap, from roughly a third at the thin end to nearly two-thirds at the thick end.9PubMed Central. Endometrial thickness as a predictor of the reproductive outcomes in fresh and frozen embryo transfer cycles
That said, 4 mm is not an absolute barrier. A case report documented a woman with an extremely thin endometrium who conceived naturally and delivered a healthy baby, which the authors highlighted as exceptional but real.10PubMed Central. Successful live birth of thin endometrium: A case report The takeaway for fertility patients is not that pregnancy at 4 mm is impossible, but that it is significantly less likely, and most clinics will try to improve lining thickness before proceeding with an embryo transfer if possible.
Tamoxifen Creates a Misleading Picture
Tamoxifen, used widely in breast cancer treatment, creates a peculiar situation with endometrial measurement. The drug acts as a weak estrogen on uterine tissue and can cause the lining to thicken even in postmenopausal women. Women who had been on tamoxifen for under five years had a median thickness of 5 mm, but those on it for five years or longer had a median of 14 mm. The critical issue is that abnormal pathology was found in a substantial proportion of both groups: about 44% of short-term users and 58% of long-term users who underwent biopsy had abnormal results.11American Journal of Roentgenology. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings
What makes tamoxifen tricky is that the drug causes changes in the tissue beneath the endometrium that make the lining look thicker on ultrasound than it actually is. It also causes a distinctive cystic appearance that can be difficult to interpret. For women on tamoxifen, a 4 mm measurement does not carry the same reassurance it would for other postmenopausal women, because the standard ultrasound thresholds were not developed in this population. Clinicians managing tamoxifen patients tend to rely more on symptoms, particularly any unexpected bleeding, rather than on thickness alone.
The Type 2 Cancer Problem
One of the more sobering findings in the research is that certain aggressive forms of endometrial cancer can exist behind a thin-looking lining. The common forms of endometrial cancer, often called type 1, are strongly linked to estrogen exposure and typically cause the lining to thicken. Type 2 cancers, which include aggressive subtypes like serous and clear-cell carcinoma, behave differently. They can arise in atrophic tissue and may not produce the thick endometrial stripe that triggers investigation.
A study of type 2 endometrial cancers found that in about 17% of cases, the endometrial measurement was below 4 mm. However, every one of those cases had at least one other abnormality visible on ultrasound, such as fluid in the uterine cavity, a mass in the muscle wall, an enlarged uterus, or an adnexal mass.12PubMed. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers The practical message is that while a thin lining is generally reassuring, the ultrasound reading should not be evaluated in isolation. If you have postmenopausal bleeding and your endometrium measures under 4 mm but the ultrasound shows other abnormalities, your doctor should still investigate further.
What Atrophic Endometrium Actually Looks Like Under the Microscope
When the lining is thin after menopause, it does not all look the same at the cellular level. Pathologists have identified several distinct forms of atrophic endometrium. Some are truly inactive, with tiny glands showing no hormonal stimulation at all. Others are weakly proliferative, meaning the glands show mild estrogen-driven activity despite the lining being very thin, often just 1 to 3.5 mm.13Middle East Fertility Society Journal. Unexplained postmenopausal uterine bleeding from atrophic endometrium: Histopathological and hormonal studies There are also mixed forms and a cystic variant where tiny glands balloon into fluid-filled spaces.
This variety matters because it explains why some postmenopausal women with thin linings still experience bleeding. The weakly proliferative type, in particular, seems to retain enough hormonal sensitivity to occasionally break down and bleed, even though the lining measures well under 4 mm on ultrasound. It is one of the reasons that “atrophic bleeding” is a recognized diagnosis: the source of the bleeding can be a fragile, thinned-out lining rather than a thickened one.
Ultrasound Is Not the Whole Story
Endometrial thickness is measured on transvaginal ultrasound by taking a double-layer measurement of the lining in the longest view of the uterus. It is a useful screening tool, but it has real limitations. It cannot distinguish between different types of tissue. A polyp, a small fibroid protruding into the cavity, and uniformly thickened endometrium can all produce the same number. And as the type 2 cancer data shows, a thin measurement does not rule out all problems.
When a standard ultrasound measurement raises questions or does not match the clinical picture, there are additional tools. Saline infusion sonography, where sterile fluid is instilled into the uterine cavity during an ultrasound, can help distinguish between a diffusely thick lining and a focal lesion like a polyp. One study comparing saline infusion sonography to hysteroscopy, the gold standard for looking inside the uterus, found that the saline-enhanced ultrasound had a sensitivity of 96% and a specificity of 88% for detecting abnormalities.14PubMed. Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium MRI is reserved for specific situations, particularly staging known endometrial cancer, where it excels at showing how deeply a tumor has invaded the uterine wall.15PubMed. Through thick and thin: a pictorial review of the endometrium
The point is that thickness alone is a single data point. It is most useful when interpreted alongside symptoms, menopausal status, medication use, and the overall appearance of the ultrasound. A 4 mm measurement in a 55-year-old with no bleeding and no medications means something very different from a 4 mm measurement in a 55-year-old on tamoxifen who is having spotting.
When Thickness Measurements Should Be Viewed with Extra Caution
Even outside of the tamoxifen scenario, certain populations warrant a closer look regardless of endometrial thickness. Women with obesity, diabetes, or hereditary cancer syndromes like Lynch syndrome carry a higher baseline risk of endometrial cancer. A review of screening strategies found strong support for personalized approaches based on these individual risk factors rather than relying on a universal thickness cutoff.16PubMed. Advances in endometrial cancer screening: a comprehensive review of current methods and emerging technologies
For these higher-risk groups, the reassurance of a 4 mm measurement carries somewhat less weight. Lynch syndrome in particular is associated with endometrial cancer that can develop at younger ages and may not follow the typical pattern of estrogen-driven thickening. Women with polycystic ovary syndrome face a different version of the problem: chronic anovulation means prolonged estrogen exposure without the counterbalancing effect of progesterone, which over time can cause the lining to become abnormal even if a single measurement happens to catch it at a relatively thin moment.
Why Pathology Does Not Always Match the Ultrasound
One of the more frustrating realities for both patients and clinicians is that endometrial thickness on ultrasound does not always correspond neatly to what pathologists find when they actually sample the tissue. A study of patients with pathologically confirmed endometrial atrophy found wide variation in their ultrasound measurements: about 21% measured at or below 4 mm, 54% were between 4 and 10 mm, and a full quarter measured above 10 mm.17PubMed. Ultrasonic presentation variation of patients with pathological evidence of endometrial atrophy That means a substantial number of women whose tissue was microscopically atrophic, essentially inactive and harmless, looked thick on ultrasound.
The reverse can also be true, as the type 2 cancer data illustrates: tissue that looks thin can harbor serious disease. The ultrasound measurement is a helpful first-pass filter, not a diagnosis. It narrows the field of possibilities and guides the next step. In most clinical scenarios, a 4 mm reading is a green light, but the light is only meaningful if you know which road you are on.
Focal Lesions That Hide Behind Normal Numbers
A polyp or small submucous fibroid can sit inside the uterine cavity and be masked by a surrounding thin lining. The overall measurement might come back at 4 or 5 mm because the ultrasound averages the thick spot with the thin surrounding tissue. Clinicians have long recognized this limitation, and the presence of focal lesions on ultrasound is treated as its own category requiring further evaluation regardless of the overall thickness reading.18PubMed. Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding
This is one reason why the ultrasound report typically includes more than just a number. Descriptions of the endometrial texture, the presence or absence of fluid in the cavity, the uniformity of the echo pattern, and the appearance of the surrounding muscle wall all contribute to the clinical interpretation. A 4 mm measurement accompanied by the words “homogeneous” and “no focal lesion” is far more reassuring than the same number with notes about irregular echoes or a possible intracavitary mass.